Search Results for:Vinicy Chan

Japanese brewer Kirin’s dairy unit draws interest from China’s top player

Lion Dairy, which makes “Big M” flavored milk and “Dare” iced coffee, could fetch about $1.4 billion.


JHL Biotech bags pre-IPO funding from Sanofi, others at $750m valuation

Proceeds will go toward ongoing development of JHL Biotech’s pipeline of drug candidates that are in phase III clinical trials.


UK’s Inspired Schools said to acquire NZ-based ACG unit from Pacific Equity

ACG Education runs schools, university programs and vocational colleges in New Zealand, Vietnam and Indonesia. Pacific Equity Partners bought the business through a leveraged buyout in September 2015.


Taiwan’s components maker Precision Motion mulls $1b-plus sale

Precision Motion Industries Inc is exploring a sale that could value the Taiwanese company at more than $1 billion.


Chinese medical researcher WuXi AppTec said to file for $1b HK offering

WuXi AppTec, which previously traded on the New York Stock Exchange, was taken private in 2015 in a $3.3 billion deal by founder Ge Li and a group of investors including Ally Bridge Group and Hillhouse Capital.


HK’s CK Infrastructure said to weigh listing of UK assets

The Asian investor built a stable of British infrastructure assets ranging from sewage to gas to rail over the last decade.


Chinese restaurant chain Haidilao to seek approval for $1b IPO

A $1 billion deal would be the largest consumer IPO this year in Hong Kong, which has been focused on transforming itself into a hub for fundraising by new-economy companies


Cerberus said to pursue deal for China HNA’s $3b Swissport unit

HNA is working with advisers to explore possibilities for Swissport including the sale of a majority stake in the business


China’s sovereign wealth fund backs $13b takeover of Yum China

The investor group considering a takeover bid for Yum China includes DCP Capital and Hillhouse.


Hong Kong’s new listing rules attract two more biotech startups

Suzhou Kintor Pharmaceuticals Inc. and Frontier Biotechnologies are planning Hong Kong stock offerings that could each raise about $300 million.